Suppr超能文献

2020 年秋季至 2021 年春季美国大学环境中的 SARS-CoV-2 再感染情况。

SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021.

机构信息

Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, 1025 E. 7th St., Bloomington, IN, 47405, USA.

Biostatistics Consulting Center, Indiana University School of Public Health-Bloomington, Bloomington, IN, USA.

出版信息

BMC Infect Dis. 2022 Jul 4;22(1):592. doi: 10.1186/s12879-022-07578-x.

Abstract

BACKGROUND

SARS-CoV-2 reinfections are a public health concern because of the potential for transmission and clinical disease, and because of our limited understanding of whether and how well an infection confers protection against subsequent infections. Despite the public health importance, few studies have reported rigorous estimates of reinfection risk.

METHODS

Leveraging Indiana University's comprehensive testing program to identify both asymptomatic and symptomatic SARS-CoV-2 cases, we estimated the incidence of SARS-CoV-2 reinfection among students, faculty, and staff across the 2020-2021 academic year. We contextualized the reinfection data with information on key covariates: age, sex, Greek organization membership, student vs faculty/staff affiliation, and testing type.

RESULTS

Among 12,272 people with primary infections, we found a low level of SARS-CoV-2 reinfections (0.6%; 0.4 per 10,000 person-days). We observed higher risk for SARS-CoV-2 reinfections in Greek-affiliated students.

CONCLUSIONS

We found evidence for low levels of SARS-CoV-2 reinfection in a large multi-campus university population during a time-period prior to widespread COVID-19 vaccination.

摘要

背景

SARS-CoV-2 的再感染是一个公共卫生关注点,因为它有传播和临床疾病的潜在风险,而且我们对感染是否以及如何提供针对后续感染的保护知之甚少。尽管具有重要的公共卫生意义,但很少有研究报告再感染风险的严格估计。

方法

利用印第安纳大学全面的检测计划来识别无症状和有症状的 SARS-CoV-2 病例,我们估计了 2020-2021 学年期间学生、教职员工中 SARS-CoV-2 再感染的发生率。我们将再感染数据与关键协变量的信息联系起来:年龄、性别、希腊组织成员身份、学生与教职员工的隶属关系以及检测类型。

结果

在 12272 名原发性感染患者中,我们发现 SARS-CoV-2 的再感染水平较低(0.6%;每 10000 人日 0.4 例)。我们观察到与希腊有关联的学生再感染 SARS-CoV-2 的风险更高。

结论

我们在 COVID-19 疫苗广泛接种之前的一段时间内,在一个大型多校区大学人群中发现了 SARS-CoV-2 再感染水平较低的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2199/9254513/ef375dc3c922/12879_2022_7578_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验